Display options
Cite
Karkinski D, Georgievski O, Dzekova-Vidimliski P, et al. Obstructive Sleep Apnea and Lipid Abnormalities. Open Access Maced J Med Sci. 2017;5(1):19-22doi: 10.3889/oamjms.2017.011.
Karkinski, D., Georgievski, O., Dzekova-Vidimliski, P., Milenkovic, T., & Dokic, D. (2017). Obstructive Sleep Apnea and Lipid Abnormalities. Open access Macedonian journal of medical sciences, 5(1), 19-22. https://doi.org/10.3889/oamjms.2017.011
Karkinski, Dimitar, et al. "Obstructive Sleep Apnea and Lipid Abnormalities." Open access Macedonian journal of medical sciences vol. 5,1 (2017): 19-22. doi: https://doi.org/10.3889/oamjms.2017.011
Karkinski D, Georgievski O, Dzekova-Vidimliski P, Milenkovic T, Dokic D. Obstructive Sleep Apnea and Lipid Abnormalities. Open Access Maced J Med Sci. 2017 Mar 15;5(1):19-22. doi: 10.3889/oamjms.2017.011. Epub 2017 Jan 18. PMID: 28293310; PMCID: PMC5320901.
Copy Download .nbib Format: NLM
Share it on

Open Access Maced J Med Sci. 2017 Mar 15;5(1):19-22. doi: 10.3889/oamjms.2017.011. Epub 2017 Jan 18.

Obstructive Sleep Apnea and Lipid Abnormalities.

Open access Macedonian journal of medical sciences

Dimitar Karkinski, Oliver Georgievski, Pavlina Dzekova-Vidimliski, Tatjana Milenkovic, Dejan Dokic

Affiliations

  1. University Clinic of Pulmonology and Allergology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia.
  2. Clinical Biochemistry, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia.
  3. University Clinic of Nephrology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia.
  4. Univesity Clinic of Endocrinology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia.

PMID: 28293310 PMCID: PMC5320901 DOI: 10.3889/oamjms.2017.011

Abstract

BACKGROUND: There has been a great interest in the interaction between obstructive sleep apnea (OSA) and metabolic dysfunction, but there is no consistent data suggesting that OSA is a risk factor for dyslipidemia.

AIM: The aim of this cross-sectional study was to evaluate the prevalence of lipid abnormalities in patients suspected of OSA, referred to our sleep laboratory for polysomnography.

MATERIAL AND METHODS: Two hundred patients referred to our hospital with suspected OSA, and all of them underwent for standard polysomnography. All patients with respiratory disturbance index (RDI) above 15 were diagnosed with OSA. In the morning after 12 hours fasting, the blood sample was collected from all patients. Blood levels of triglycerides, total cholesterol, high-density lipoprotein cholesterol (HDL) and low-density lipoprotein cholesterol (LDL), were determined in all study patients. In the study, both OSA positive and OSA negative patients were divided according to the body mass index (BMI) in two groups. The first group with BMI ≤ 30 kg/m^2 and the second group with BMI > 30 kg/m^2.

RESULTS: OSA positive patients with BMI ≤ 30 kg/m^2 had statistically significant higher levels of triglycerides and total cholesterol, and statistically significant lower level of HDL compared to OSA negative patients with BMI ≤ 30. There were no statistically significant differences in age and LDL levels between these groups. OSA positive patients with BMI > 30 kg/m^2 had higher levels of triglycerides, total cholesterol and LDL and lower levels of HDL versus OSA negative patients with BMI > 30 kg/m^2, but without statistically significant differences.

CONCLUSION: OSA and obesity are potent risk factors for dyslipidemias. OSA could play a significant role in worsening of lipid metabolism in non-obese patients. But in obese patients, the extra weight makes the metabolic changes of lipid metabolism, and the role of OSA is not that very important like in non-obese patients.

Keywords: body mass index (BMI); obstructive sleep apnea (OSA); plasma lipids

References

  1. Diabetes Care. 2004 Sep;27(9):2222-8 - PubMed
  2. Arch Intern Med. 2008 Aug 11;168(15):1617-24 - PubMed
  3. Sleep Med. 2009 Sep;10(8):882-6 - PubMed
  4. Eur Heart J. 2004 May;25(9):735-41 - PubMed
  5. N Engl J Med. 1993 Apr 29;328(17):1230-5 - PubMed
  6. Lancet. 2009 Jan 3;373(9657):82-93 - PubMed
  7. Am J Epidemiol. 2001 Jul 1;154(1):50-9 - PubMed
  8. Obesity (Silver Spring). 2013 Apr;21(4):847-51 - PubMed
  9. Eur Respir J. 2009 Jul;34(1):243-60 - PubMed
  10. Chest. 2002 Sep;122(3):829-39 - PubMed
  11. Prog Cardiovasc Dis. 2009 Jan-Feb;51(4):279-84 - PubMed
  12. Respir Med. 2006 Jun;100(6):980-7 - PubMed
  13. J Clin Sleep Med. 2012 Oct 15;8(5):597-619 - PubMed
  14. Appl Physiol Nutr Metab. 2007 Feb;32(1):4-12 - PubMed
  15. PLoS One. 2010 Aug 11;5(8):e12065 - PubMed
  16. Curr Opin Endocrinol Diabetes Obes. 2010 Apr;17 (2):161-5 - PubMed
  17. Chest. 2000 Sep;118(3):580-6 - PubMed
  18. Intern Med. 2008;47(21):1843-9 - PubMed
  19. Thorax. 2004 Sep;59(9):777-82 - PubMed
  20. Eur Respir J. 2007 Jan;29(1):156-78 - PubMed
  21. Atherosclerosis. 2006 Feb;184(2):377-82 - PubMed
  22. Sleep Med. 2007 Jan;8(1):12-7 - PubMed
  23. Physiol Rev. 2010 Jan;90(1):47-112 - PubMed

Publication Types